Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

RSV vaccines could get broader CDC backing for adults aged 50-59 at risk after an endorsement from an agency's expert panel. Read more here.

In March, short sellers collectively increased their negative bets on the broader healthcare industry, as indicated by a rise ...

When we think about the protection that can be provided by a comprehensive immunization plan, we think in terms of lifetimes. It’s vital that we also remember the important moments that make up each ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...